Mostrando 10 resultados de: 14
Publisher
New England Journal of Medicine(2)
Sleep Medicine(2)
American Journal of Hypertension(1)
BMJ Global Health(1)
Diabetes Care(1)
Área temáticas
Enfermedades(8)
Medicina y salud(8)
Fisiología humana(4)
Salud y seguridad personal(4)
Farmacología y terapéutica(3)
Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)
ArticleAbstract: Background and Purpose The association of dyslipidemia with stroke has been inconsistent, which mayPalabras claves:Apolipoproteins, Case-control, dyslipidemia, Lipoproteins, risk factor, strokeAutores:Avezum A.J., Chin S.L., Czlonkowska A., Damasceno A., Dans A.L., DIaz R., Diener H.C., ElSayed A., Ferguson J., Hankey G.J., Hussain F.A., Iqbal R., Iversen H.K., Judge C., Lanas F., Langhorne P., Lisheng L., Málaga G., McQueen M.J., Mondo C.K., Nilanont Y., Ogah O.S., Ogunniyi A., Oguz A., Oveisgharan S., O’donnell M.J., Pais P., Paré G., PATRICIO LOPEZ -JARAMILLO, Peñaherrera E., Pogosova N., Rangarajan S., Rao-Melacini P., Rosengren A., Rumboldt Z., Ryglewicz D., Sniderman A., Wang X., Weimar C., Xavier D., Yusoff K., Yusuf S., Yusufali A.M., Zhang H.Fuentes:googlescopusAssociation of bedtime with mortality and major cardiovascular events: an analysis of 112,198 individuals from 21 countries in the PURE study
ArticleAbstract: Objectives: This study aimed to examine the association of bedtime with mortality and major cardiovaPalabras claves:Bedtime, cardiovascular events, MortalityAutores:Abat M.E.M., Alhabib K.F., Avezum A.J., Bahonar A., Bangdiwala S.I., Chifamba J., DIaz R., Gupta R., Hu B., Iqbal R., Kruger L., Lanas F.T., Lear S.A., Mohan V., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rosengren A., Soman B., Wang C., Wei L., Yeates K.E., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusAssociations of Fish Consumption with Risk of Cardiovascular Disease and Mortality among Individuals with or without Vascular Disease from 58 Countries
ArticleAbstract: Importance: Cohort studies report inconsistent associations between fish consumption, a major sourcePalabras claves:Autores:Alhabib K.F., Avezum A.J., Chifamba J., Dagenais G.R., Dans A.M., Dehghan M., DIaz R., Gerstein H.C., Gulec S., Gupta R., Hu W., Iqbal R., Kaur M., Khatib R., Lanas F.T., Lear S.A., Mente A., Mohammadifard N., Mohan D., Mohan V., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rosengren A., Swaminathan S., Szuba A., Teo K.K., Vijayakumar K., Wei L., Wentzel-Viljoen E., Wielgosz A., Yeates K.E., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusAvailability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
ArticleAbstract: Objectives We aimed to examine the relationship between access to medicine for cardiovascular diseasPalabras claves:epidemiology, Health policy, prevention strategies, PUBLIC HEALTH, TreatmentAutores:Alhabib K.F., Avezum A.J., Bahonar A., Chifamba J., Chow C.K., Dans A.M., DIaz R., Gulec S., Gupta R., Hu B., Kazmi K., Khatib R., Kruger L., Kumar R., Lanas F.T., Lear S.A., Li W., Marschner S., Mckee M., Mony P.K., Nguyen T.N., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Teo K.K., Yeates K.E., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusAntihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Tria
ArticleAbstract: Background and Purpose: The HOPE-3 trial (Heart Outcomes Prevention Evaluation-3) found that antihypPalabras claves:Blood pressure, candesartan, Cardiovascular disease, Lipoprotein, Primary Prevention, statinAutores:Avezum A.J., Bosch J.J., Chazova I.E., Dagenais G.R., Gao P., Hart R.G., Held C., Khunti K., Leiter L.A., Lewis B.S., Lonn E.M., Pais P., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Reid C.M., Sliwa K., Toff W.D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusContrasting associations between diabetes and cardiovascular mortality rates in low-, middle-, and high-income countries: Cohort study data from 143,567 individuals in 21 countries in the pure study
ArticleAbstract: OBJECTIVE We aimed to compare cardiovascular (CV) events, all-cause mortality, and CV mortality ratePalabras claves:Autores:Alhabib K.F., Anjana R.M., Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., DIaz R., Gerstein H.C., Gupta R., Hu L., Iqbal R., Iype T., Karsidag K., Kruger L., Lakshmi P.V.M., Lanas F.T., Lear S.A., Mohan V., Mony P.K., Noorhassim I., Palileo-Villanueva L.M., PATRICIO LOPEZ -JARAMILLO, Rahman M.O., Rangarajan S., Rosengren A., Sheridan P., Teo K.K., Venkatesan U., Wei L., Yeates K.E., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusGlycemic index, glycemic load, and cardiovascular disease and mortality
ArticleAbstract: BACKGROUND Most data regarding the association between the glycemic index and cardiovascular diseasePalabras claves:Autores:Alhabib K.F., Avezum A.J., Bangdiwala S.I., Chifamba J., Dehghan M., DIaz R., Iqbal R., Jenkins D.J.A., Khatib R., Lanas F.T., Li W., Liu X., Mente A., Mohammadifard N., Mohan V., Noorhassim I., Oguz A., PATRICIO LOPEZ -JARAMILLO, Pepe A., Poirier P., Rangarajan S., Rosengren A., Srichaikul K., Swaminathan S., Teo K.K., Yeates K.E., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusErratum: ‘Corrigendum to “Association of bedtime with mortality and major cardiovascular events: an analysis of 112,198 individuals from 21 countries in the PURE study” [Sleep Medicine 80 (2021) 265–272]’ (Sleep Medicine (2021) 80 (265–272), (S1389945721000745), (10.1016/j.sleep.2021.01.057))
OtherAbstract: The authors regret < Co-author Sadi Gulec (Ankara University School of Medicine, Ankara, Turkey) wasPalabras claves:Autores:Abat M.E.M., Alhabib K.F., Avezum A.J., Bahonar A., Bangdiwala S.I., Chifamba J., DIaz R., Gulec S., Gupta R., Hu B., Iqbal R., Kruger L., Lanas F.T., Lear S.A., Mohan V., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rosengren A., Soman B., Wang C., Wei L., Yeates K.E., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:scopusLowering cholesterol, blood pressure, or both to prevent cardiovascular events: Results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
ArticleAbstract: Aims: Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) ePalabras claves:Cardiovascular disease, Primary Prevention, statinsAutores:Avezum A.J., Bosch J.J., Dagenais G.R., Dans A.M., DIaz R., Held C., Jansky P., Joseph P.G., Jung H., Keltai K., Keltai M., Khunti K., Leiter L.A., Lewis B.S., Liu L., Lonn E.M., Pais P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Peters R.J.G., Piegas L.S., Reid C.M., Sliwa K., Toff W.D., Varigos J.D., Xavier D., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusUrinary Sodium and Potassium, and Risk of Ischemic and Hemorrhagic Stroke (INTERSTROKE): A Case-Control Study
ArticleAbstract: Although low sodium intake (<2 g/day) and high potassium intake (>3.5 g/day) are proposed as publicPalabras claves:Blood pressure, Hypertension, Intracerebral Hemorrhage, Ischemic stroke, potassium, Sodium, strokeAutores:Al Hussain F., Avezum A.J., Chin S.L., Czlonkowska A., Damasceno A., Dans A.M., DIaz R., ElSayed A., Ferguson J., Hankey G.J., Iversen H.K., Judge C., Lanas F.T., Langhorne P., Lisheng L., Málaga G., Mondo C.K., Ogah O.S., Ogunniyi A., Oguz A., Oveisgharan S., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Pogosova N., Rangarajan S., Rao-Melacini P., Rosengren A., Rumboldt Z., Ryglewicz D., Smyth A., Wang X., Weimar C., Xavier D., Yusoff K., Yusuf S., Yusufali A.M., Zhang H.Fuentes:googlescopus